The feasible immunotargeted therapy for cervical neuroendocrine tumors was discussed by studying the expression of PD‐L1, PARP1, 4 kinds of mismatch repair proteins and p53 in cervical cancer and case analysis. This evidence concerns the gene CD274 and cervical cancer.